Opioid Dispensing Device for Post-Operative Pain in Cancer Patients
Recruiting · NCT05585788 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This research study will evaluate the use of, and participants experience with, a new device called Addinex that safely stores and dispenses opioid medication. The purpose of this study is to evaluate the use of the Addinex device in cancer patients undergoing cancer-related surgery that require pain control with opioids after the surgery. Participants will be asked to answer questions about their medical history and background, fill out questionnaires, use a mobile application associated with the device, and undergo a phone interview one month after stopping use of the device. This study aims to find out how participants like using the Addinex device as opposed to a traditional pill bottle. Results of this study will help determine if the Addinex device could be useful to patients in the future after surgeries, as opposed to typical pill bottles.
Who can take part
Inclusion criteria
- Adult patients (age greater than or equal to 18 years)
- Planned for major cancer-related surgery and expected to receive a postoperative opioid prescription
- Must speak English or Spanish
- Must have access to a smartphone or an alternative smart device (e.g., iPhone, Android phone, iPad, Surface, etc.).
- Co-enrollment in trials involving pharmacologic therapy is allowed
Exclusion criteria
- Patients who are taking opioids daily prior to the surgical procedure
- Patients unable to physically utilize the device
- Patients unable to self-administer medications
- Patients uncomfortable with using iPhone or iPad-based technology
Where it is running
1 location listed across 1 US state.
- Columbia University Medical Center - New York, New York, United States